Trial Details
COMPLETEDBasic Information
| Clinical ID | c3114 |
|---|---|
| Identifier | NCT02513459 |
| Trial Title | A Long Term Extension Trial of BI 655066/ABBV-066 (Risankizumab), in Patients With Moderately to Severely Active Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Crohn Disease |
| Interventions | DRUG: Risankizumab 600 mg IV|DRUG: Risankizumab 180 mg SC |
Participant Information
| Sponsor | AbbVie |
|---|---|
| City | Chevy Chase |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2015-09-16 |
|---|---|
| Primary Completion Date | 2019-06-19 |
| Completion Date | 2019-06-19 |